A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC™) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies
✍ Scribed by R.H.A Green; D Watson; S Buchanan; A.E Morrison
- Book ID
- 117648169
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 62 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1473-0502
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A randomised crossover trial of two separators was undertaken to compare the mononuclear cell, CD34+ cell and CFU-GM yield, in patients (<61 years) with previously untreated symptomatic multiple myeloma. After first-line therapy, all patients received mobilising chemotherapy (cyclophosphamide 4 g/m
A prospective study was undertaken to compare the mononuclear cell, CD34+ cell, and CFU-GM yields of the Haemonetics MCS-3P and the Cobe Spectra cell separators in ten patients (nine multiple myeloma and one non-Hodgkin lymphoma) on two consecutive days after mobilization with high-dose filgrastim (